Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of alternative interventions among hospitalized, cognitively impaired older adults.

Journal of comparative effectiveness research·2016
Same author

Comparison of evidence-based interventions on outcomes of hospitalized, cognitively impaired older adults.

Journal of comparative effectiveness research·2014
Same author

High-value transitional care: translation of research into practice.

Journal of evaluation in clinical practice·2011
Same author

Advanced practice nurse strategies to improve outcomes and reduce cost in elders with heart failure.

Disease management : DM·2006
Same author

A message from the American Association of Critical-Care Nurses.

American journal of critical care : an official publication, American Association of Critical-Care Nurses·2005
Same author

Transitional care of older adults hospitalized with heart failure: a randomized, controlled trial.

Journal of the American Geriatrics Society·2004

Related Experiment Video

Updated: Jul 16, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Modifying women's risk for cardiovascular disease.

Kathleen M McCauley1

  • 1University of Pennsylvania School of Nursing, Philadelphia, PA 19104, USA. kmccauley@nursing.upenn.edu

Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN
|March 21, 2007
PubMed
Summary

Adopting a healthy lifestyle, including regular exercise, not smoking, a balanced diet, and maintaining a normal weight, can prevent 82% of cardiovascular disease events in women. Partnering with a healthcare provider is key for managing blood pressure and cholesterol.

More Related Videos

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome
06:04

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome

Published on: September 27, 2024

Related Experiment Videos

Last Updated: Jul 16, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome
06:04

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome

Published on: September 27, 2024

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Women's Health

Background:

  • Cardiovascular disease (CVD) remains a significant health concern for women.
  • Understanding specific risk factors and prevention strategies tailored for women is crucial.

Purpose of the Study:

  • To outline current evidence-based recommendations for reducing cardiovascular disease risk in women.
  • To synthesize guidelines for primary and secondary prevention of CVD in the female population.

Main Methods:

  • Comprehensive literature search of Medline databases (1990-2006) and scientific association websites.
  • Inclusion of randomized controlled trials, scientific statements, and clinical practice guidelines.
  • Focus on factors contributing to women's specific cardiovascular risks and current management strategies.

Main Results:

  • Regular physical activity (≥30 minutes/day, most days) is essential.
  • Smoking cessation, a diet rich in whole grains, fruits, vegetables, and low-fat protein, and maintaining a normal weight are critical.
  • Achieving normal blood pressure (115/75 mm Hg) and optimal lipoproteins, with pharmacotherapy if needed, are key targets.

Conclusions:

  • A combination of a healthy lifestyle and proactive healthcare management can prevent a substantial majority (82%) of cardiovascular disease events in women.
  • Empowering women with knowledge and tools for CVD risk reduction is paramount.
  • Ongoing collaboration between patients and healthcare providers is vital for effective cardiovascular health management in women.